NCT06347133Phase 3Completed

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Study sponsor: Arrowhead Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-06-01Actual
Enrollment · participants1456Actual
Source updated2026-09-25Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source

· 2 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

May 2026

+ After

1 Jun 2026

Check registry source